1. Home
  2. ABCL vs ABL Comparison

ABCL vs ABL Comparison

Compare ABCL & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • ABL
  • Stock Information
  • Founded
  • ABCL 2012
  • ABL 2004
  • Country
  • ABCL Canada
  • ABL United States
  • Employees
  • ABCL N/A
  • ABL N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • ABL Investment Managers
  • Sector
  • ABCL Health Care
  • ABL Finance
  • Exchange
  • ABCL Nasdaq
  • ABL Nasdaq
  • Market Cap
  • ABCL 818.2M
  • ABL 727.7M
  • IPO Year
  • ABCL 2020
  • ABL N/A
  • Fundamental
  • Price
  • ABCL $2.97
  • ABL $7.45
  • Analyst Decision
  • ABCL Buy
  • ABL Strong Buy
  • Analyst Count
  • ABCL 3
  • ABL 4
  • Target Price
  • ABCL $8.00
  • ABL $13.88
  • AVG Volume (30 Days)
  • ABCL 3.2M
  • ABL 234.4K
  • Earning Date
  • ABCL 02-18-2025
  • ABL 11-07-2024
  • Dividend Yield
  • ABCL N/A
  • ABL N/A
  • EPS Growth
  • ABCL N/A
  • ABL N/A
  • EPS
  • ABCL N/A
  • ABL N/A
  • Revenue
  • ABCL $32,962,000.00
  • ABL $102,407,324.00
  • Revenue This Year
  • ABCL N/A
  • ABL $70.90
  • Revenue Next Year
  • ABCL $36.56
  • ABL $65.20
  • P/E Ratio
  • ABCL N/A
  • ABL N/A
  • Revenue Growth
  • ABCL N/A
  • ABL 77.68
  • 52 Week Low
  • ABCL $2.34
  • ABL $6.75
  • 52 Week High
  • ABCL $5.62
  • ABL $13.25
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 50.75
  • ABL 45.15
  • Support Level
  • ABCL $2.81
  • ABL $6.75
  • Resistance Level
  • ABCL $3.09
  • ABL $7.65
  • Average True Range (ATR)
  • ABCL 0.20
  • ABL 0.35
  • MACD
  • ABCL -0.02
  • ABL 0.01
  • Stochastic Oscillator
  • ABCL 30.28
  • ABL 54.69

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About ABL Abacus Life Inc.

Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.

Share on Social Networks: